Arthritis drug halted early in trial for rare tumor syndrome
Disease control
Terminated
This study tested whether leflunomide, a drug used for rheumatoid arthritis, could slow or shrink tumors in people with a rare genetic condition called MEN1. MEN1 causes tumors in multiple glands and reduces life expectancy. The trial aimed to see if six months of daily leflunomi…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC